Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |